We use a few cookies

Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.

Skip to main content
Home/e-Resources/Life Sciences/Ethnobotanical study of the toxicity of Ecballium elaterium (L.) A. Rich in the Northest of Algeria
PeriodicalsLife Sciences

Ethnobotanical study of the toxicity of Ecballium elaterium (L.) A. Rich in the Northest of Algeria

Checking your access to this record.

Abstract & Overview

Medicinal plants still remain a source of medical care in developing countries, in the absence of a modern medical system. The use of herbal medicine is deeply rooted in our culture, because Algeria is renowned for the richness of its medicinal flora which includes hundreds of plant species. Ecballium elaterium (L.) A. Rich., the species reported in this study is traditionally used in Algeria for a wide range of illnesses. The aim of this study was to evaluate the potential toxicity of it. Many herbalists (two hundred) in different regions in Northern Algeria (Tébessa, Khenchela, Oum El Bouaghi, Constantine, Skikda were questioned to recognize the toxicological concern of E. elaterium in Algerian traditional medicine in these regions.

Cite this record

R. Amrouni, Nabila Souilah, Hamdi Bendıf, Nassera Daoud, Hacène Laredj (2020). Ethnobotanical study of the toxicity of Ecballium elaterium (L.) A. Rich in the Northest of Algeria. Journal of Medicinal Botany, 9–13. https://doi.org/10.25081/jmb.2020.v4.6181

Copy in another style

Amrouni, R., Souilah, N., Bendıf, H., Daoud, N., & Laredj, H. (2020). Ethnobotanical study of the toxicity of Ecballium elaterium (L.) A. Rich in the Northest of Algeria. Journal of Medicinal Botany, 9–13. https://doi.org/10.25081/jmb.2020.v4.6181
Author names are used as deposited, so check their order before you submit.

Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.